Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROZANOLIXIZUMAB vs RUFINAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROZANOLIXIZUMAB vs RUFINAMIDE: Safety Overview

Metric ROZANOLIXIZUMAB RUFINAMIDE
Total FAERS Reports 303 871
Deaths Reported 9 27
Death Rate 3.0% 3.1%
Hospitalizations 114 229
Average Patient Age 61.3 yrs 16.9 yrs
% Female Patients 60.9% 50.2%
FDA Approval Date N/A Apr 15, 2025
Manufacturer UCB, Inc. Aurobindo Pharma Limited
Route SUBCUTANEOUS ORAL
Marketing Status N/A Discontinued